Release 5 R6 Ballot (1st Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationAdministration/medadmin0304 (Narrative)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationAdministration .

Generated Narrative: MedicationAdministration

Resource MedicationAdministration "medadmin0304"

status : completed

Medications

- Reference
*

code : Alemtuzumab 10mg/ml (Lemtrada) alemtuzumab 10 MG/ML [Lemtrada] ( RxNorm #1594660)

subject : Patient/pat1: Donald Duck "Donald DUCK"

encounter : Encounter/f001: encounter who leads to this prescription

occurence : 2015-01-15T04:30:00+01:00 --> 2015-01-15T14:30:00+01:00

performer

Actors

- Reference
* Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

- Reference
* Condition/f202

request : MedicationRequest/medrx0319

Dosages

- Text Route Method Dose
* Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk Intravenous route (qualifier value) ( SNOMED CT #47625008) Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002) 3 mg (Details: UCUM code mg = 'mg')

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.